Biofil Chemicals and Pharmaceuticals Limited
NSE: BIOFILCHEM.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ketan Shah
- Employees
- 26
- Headquarters
- Indore, India
- IPO year
- 2017
- Market cap
- ₹556.1M
- Website
- https://www.biofilgroup.net
Loading BIOFILCHEM…
Loading profile data…Frequently asked questions about BIOFILCHEM
What does Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) do?
Biofil Chemicals and Pharmaceuticals Limited engages in the pharmaceutical and chemical businesses primarily in India. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and...
Where does BIOFILCHEM.NS trade?
Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) trades on the National Stock Exchange of India.
What sector is BIOFILCHEM.NS in?
Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Biofil Chemicals and Pharmaceuticals Limited?
Ketan Shah is the chief executive officer of Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS).
Where is Biofil Chemicals and Pharmaceuticals Limited headquartered?
Biofil Chemicals and Pharmaceuticals Limited is headquartered in India.
Does BIOFILCHEM.NS pay a dividend?
Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIOFILCHEM.NS go public?
Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM.NS) completed its initial public offering in 2017.